Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Growth hormone therapy in young children with Down syndrome and a clinical comparison of Down and Prader-Willi syndromes.

Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society - 1 Apr 2000

Annerén G, Tuvemo T, Gustafsson J

Abstract excerpt

The genetic disorders Prader-Willi syndrome and Down syndrome have a number of features in common, for example, both growth and mental retardation. Growth hormone (GH) treatment is becoming part of the clinical management of children with Prader-Willi syndrome, but in children with Down syndrome, such therapy is still on a research level. In this review, we compare the clinical phenotypes of the two syndromes,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Body Height
Share to Down Syndrome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Growth Hormone

Share to Infant

Share to Intellectual Disability

Share to Phenotype

Share to Prader-Willi Syndrome

Share to Time Factors

Source

Identifiers

PMID: 10984260
DOI: 10.1016/s1096-6374(00)80016-7

Genes

SDS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Growth hormone therapy in young children with Down syndrome and a clinical comparison of Down and Prader-Willi syndromes.PMID 10984260Read ↗

Update in growth hormone therapy of children.Semantic proximity Read ↗

Growth Hormone Treatment in Patients With KBG Syndrome: Novel Insights, Challenges and Recommendations From Six New Patients and Literature Review.Semantic proximity Read ↗

Growth hormone secretion and its effect on height in pediatric patients with different genotypes of Prader-Willi syndrome.Semantic proximity Read ↗

Schaaf-Yang Syndrome: Clinical Phenotype and Effects of 4 years of Growth Hormone Treatment.Semantic proximity Read ↗

Achieving Optimal Short- and Long-term Responses to Paediatric Growth Hormone TherapySemantic proximity Read ↗

Diagnosis and management of growth hormone deficiency in childhood and adolescence. Part 1: diagnosis of growth hormone deficiency.Semantic proximity Read ↗

Developmental profiles in young children with Prader-Labhart-Willi syndrome: effects of weight and therapy with growth hormone or coenzyme Q10.Semantic proximity Read ↗

Growth hormone therapy in Noonan syndrome: growth response and characteristics.Semantic proximity Read ↗

Safety and Effectiveness of Recombinant Human Growth Hormone in Children with Turner Syndrome: Data from the PATRO Children StudySemantic proximity Read ↗

Good response to long-term therapy with growth hormone in a patient with 9p trisomy syndrome: A case report and review of the literature.Semantic proximity Read ↗

Growth Hormone Therapy in Children with Kabuki Syndrome: 1-year Treatment Results.Semantic proximity Read ↗

Why Treat girls with Turner Syndrome with Growth Hormone? Growth and Beyond.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.